Document is current
Any future updates will be listed below
-
Authors
Fleming, Stephen J. http://orcid.org/0000-0002-1885-4405
Chaffin, Mark D. http://orcid.org/0000-0002-1234-5562
Arduini, Alessandro http://orcid.org/0000-0002-0038-8741
Akkad, Amer-Denis
Banks, Eric
Marioni, John C.
Philippakis, Anthony A.
Ellinor, Patrick T. http://orcid.org/0000-0002-2067-0533
Babadi, Mehrtash http://orcid.org/0000-0003-1829-8397
- License Information
-
More Information
Article History
Received: 10 July 2022
Accepted: 13 June 2023
First Online: 7 August 2023
Competing interests
: A.-D.A. is an employee of Bayer US LLC (a subsidiary of Bayer AG) and may own stock in Bayer AG. A.A.P. is employed as a venture partner at Google Ventures, and he is also supported by a grant from Bayer AG to the Broad Institute focused on machine learning for clinical trial design. P.T.E. is supported by a grant from Bayer AG to the Broad Institute focused on the genetics and therapeutics of cardiovascular diseases. P.T.E. has also served on advisory boards or consulted for Bayer AG, Quest Diagnostics, MyoKardia and Novartis. The other authors declare no competing interests.
